Skip to main content

Peer Review reports

From: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis

Original Submission
15 Sep 2022 Submitted Original manuscript
23 Sep 2022 Reviewed Reviewer Report
10 Oct 2022 Reviewed Reviewer Report
14 Oct 2022 Reviewed Reviewer Report
18 Oct 2022 Author responded Author comments - Mengdie Shen
Resubmission - Version 2
18 Oct 2022 Submitted Manuscript version 2
21 Oct 2022 Reviewed Reviewer Report
5 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Nov 2022 Editorially accepted
19 Nov 2022 Article published 10.1186/s12884-022-05191-z

You can find further information about peer review here.

Back to article page